GSK PLC GSK shares advanced 3.35% to £14.02 Monday, on what proved to be an all-around great trading session for the stock ...

The new collaboration between GSK and the Univeristy of Oxford aims to explore cancer prevention through vaccination.

Chip giant Nvidia ( NVDA) was more than 11% lower in the first hour of US trading. Industry peer ASML ( ASML) lost 8%, while Arm ( ARM ), Broadcom ( AVGO ), and Micron Technology ( MU) also got ...

The FDA will review a new prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted).

While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.

Oxford University and pharmaceutical giant GSK are creating a new cancer vaccine to prevent the disease from developing. The partnership intends to create a vaccine or vaccines which target cells at ...

This Fool considers how two low-risk and well-established FTSE shares could offer stability and growth during a period of market volatility.

Scientists at Oxford University, which pioneered Covid-19 vaccines, turn attention to ‘detecting the undetectable’ and ...

GSK plc (LSE/NYSE: GSK) today announced that the European Medicines Agency (EMA) has accepted for review the regulatory application of a prefilled syringe presentation of Shingrix (GSK’s Recombinant ...

The pharma group has pledged up to £50 million ($62.5 million) in funding over three years for the initiative, which builds ...

(Alliance News) - Pharmaceutical firm GSK PLC and the University of Oxford are creating a new cancer vaccine to prevent the disease from developing. The partnership intends to create a vaccine or ...

GSK and Oxford researchers to create cancer vaccine to stop disease developing - GSK will invest up to £50 million in the new ...